Overexpression of F0F1-ATP synthase α suppresses mutant huntingtin aggregation and toxicity in vitro

Biochemical and Biophysical Research Communications

Volumn 390, Issue 4, 2009, Pages 1294-1298

  Wang, Hong Quan ^a   Xu, Yu Xia ^a   Zhao, Xiao Yan ^a   Zhao, Hong ^a   Yan, Jie ^a   Sun, Xiao Bo ^a   Guo, Jing Chun ^a   Zhu, Cui Qing ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

ATP synthase ; HSP; Huntingtin; Overexpression

Indexed keywords

HUNTINGTIN; POLYGLUTAMINE; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATE SYNTHASE; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATE SYNTHASE ALPHA; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL DEATH; CELL EXPANSION; CONTROLLED STUDY; CYTOTOXICITY; FILTER TRAP ASSAY; GENE OVEREXPRESSION; GENE REPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IN VITRO STUDY; MUTANT; NERVE CELL; NEUROTOXICITY; PRIORITY JOURNAL; PROTEIN AGGREGATION; TELOMERIC REPEAT AMPLIFICATION PROTOCOL; WESTERN BLOTTING;

ANIMALS; APOPTOSIS; CELL LINE, TUMOR; HUMANS; HUNTINGTON DISEASE; MICE; NERVE TISSUE PROTEINS; NUCLEAR PROTEINS; PEPTIDES; PROTON-TRANSLOCATING ATPASES; RATS;

EUKARYOTA; RATTUS;

EID: 70450253167     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2009.10.139     Document Type: Article

References (42)

1. Ordway J., Tallaksen-Greene S., Gutekunst C., Bernstein E., Cearley J., Wiener H., Dure L.T., Lindsey R., Hersch S., Jope R., Albin R., and Detloff P. Ectopically expressed CAG repeats cause intranuclear inclusions and a progressive late onset neurological phenotype in the mouse. Cell 91 (1997) 753-763
2. Wanker E. Protein aggregation and pathogenesis of Huntington's disease: mechanisms and correlations. Biol Chem 381 (2000) 937-942
3. Scherzinger E., Lurz R., Turmaine M., Mangiarini L., Hollenbach B., Hasenbank R., Bates G., Davies S., Lehrach H., and Wanker E. Huntingtin-encoded polyglutamine expansions form amyloid-like protein aggregates in vitro and in vivo. Cell 90 (1997) 549-558
4. Kaminosono S., Saito T., Oyama F., Ohshima T., Asada A., Nagai Y., Nukina N., and Hisanaga S. Suppression of mutant huntingtin aggregate formation by Cdk5/p35 through the effect on microtubule stability. J. Neurosci. 28 (2008) 8747-8755
5. Lee W., Yoshihara M., and Littleton J. Cytoplasmic aggregates trap polyglutamine-containing proteins and block axonal transport in a Drosophila model of Huntington's disease. Proc. Natl. Acad. Sci. USA 101 (2004) 3224-3229
6. Usdin M., Shelbourne P., Myers R., and Madison D. Impaired synaptic plasticity in mice carrying the Huntington's disease mutation. Hum. Mol. Genet. 8 (1999) 839-846
7. Ross C. Polyglutamine pathogenesis: emergence of unifying mechanisms for Huntington's disease and related disorders. Neuron 35 (2002) 819-822
8. Evert B., Wüllner U., and Klockgether T. Cell death in polyglutamine diseases. Cell Tissue Res. 301 (2000) 189-204
9. DiFiglia M., Sapp E., Chase K., Davies S., Bates G., Vonsattel J., and Aronin N. Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain. Science 277 (1997) 1990-1993
10. Tobin A., and Signer E. Huntington's disease: the challenge for cell biologists. Trends Cell Biol. 10 (2000) 531-536
11. Harjes P., and Wanker E. The hunt for huntingtin function: interaction partners tell many different stories. Trends Biochem. Sci. 28 (2003) 425-433
12. Gauthier L., Charrin B., Borrell-Pagès M., Dompierre J., Rangone H., Cordelières F., De Mey J., MacDonald M., Lessmann V., Humbert S., and Saudou F. Huntingtin controls neurotrophic support and survival of neurons by enhancing BDNF vesicular transport along microtubules. Cell 118 (2004) 127-138
13. Li S., and Li X. Huntingtin-protein interactions and the pathogenesis of Huntington's disease. Trends Genet. 20 (2004) 146-154
14. Cattaneo E., Zuccato C., and Tartari M. Normal huntingtin function: an alternative approach to Huntington's disease. Nat. Rev. Neurosci. 6 (2005) 919-930
15. Bennett E., Shaler T., Woodman B., Ryu K., Zaitseva T., Becker C., Bates G., Schulman H., and Kopito R. Global changes to the ubiquitin system in Huntington's disease. Nature 448 (2007) 704-708
16. Kazantsev A., Walker H., Slepko N., Bear J., Preisinger E., Steffan J., Zhu Y., Gertler F., Housman D., Marsh J., and Thompson L. A bivalent huntingtin binding peptide suppresses polyglutamine aggregation and pathogenesis in Drosophila. Nat. Genet. 30 (2002) 367-376
17. Sánchez I., Mahlke C., and Yuan J. Pivotal role of oligomerization in expanded polyglutamine neurodegenerative disorders. Nature 421 (2003) 373-379
18. Heiser V., Scherzinger E., Boeddrich A., Nordhoff E., Lurz R., Schugardt N., Lehrach H., and Wanker E. Inhibition of huntingtin fibrillogenesis by specific antibodies and small molecules: implications for Huntington's disease therapy. Proc. Natl. Acad. Sci. USA 97 (2000) 6739-6744
19. Nagai Y., Tucker T., Ren H., Kenan D., Henderson B., Keene J., Strittmatter W., and Burke J. Inhibition of polyglutamine protein aggregation and cell death by novel peptides identified by phage display screening. J. Biol. Chem. 275 (2000) 10437-10442
20. Yoshida M., Muneyuki E., and Hisabori T. ATP synthase - a marvellous rotary engine of the cell. Nat. Rev. Mol. Cell Biol. 2 (2001) 669-677
21. Futai M., Omote H., Sambongi Y., and Wada Y. Synthase (H(+) ATPase): coupling between catalysis, mechanical work, and proton translocation. Biochim. Biophys. Acta 1458 (2000) 276-288
22. Luis A., Alconada A., and Cuezva J. The alpha regulatory subunit of the mitochondrial F1-ATPase complex is a heat-shock protein. Identification of two highly conserved amino acid sequences among the alpha-subunits and molecular chaperones. J. Biol. Chem. 265 (1990) 7713-7716
23. Gray R., Grasso D., Maxwell R., Finnegan P., Nagley P., and Devenish R. Identification of a 66 kDa protein associated with yeast mitochondrial ATP synthase as heat shock protein hsp60. FEBS Lett. 268 (1990) 265-268
24. Ferrer I., Perez E., Dalfó E., and Barrachina M. Abnormal levels of prohibitin and ATP synthase in the substantia nigra and frontal cortex in Parkinson's disease. Neurosci. Lett. 415 (2007) 205-209
25. Basso M., Giraudo S., Corpillo D., Bergamasco B., Lopiano L., and Fasano M. Proteome analysis of human substantia nigra in Parkinson's disease. Proteomics 4 (2004) 3943-3952
26. Schmidt C., Lepsverdize E., Chi S., Das A., Pizzo S., Dityatev A., and Schachner M. Amyloid precursor protein and amyloid beta-peptide bind to ATP synthase and regulate its activity at the surface of neural cells. Mol. Psychiatry 13 (2008) 953-969
27. Lovell M., Xiong S., Markesbery W., and Lynn B. Quantitative proteomic analysis of mitochondria from primary neuron cultures treated with amyloid beta peptide. Neurochem. Res. 30 (2005) 113-122
28. Sergeant N., Wattez A., Galván-valencia M., Ghestem A., David J., Lemoine J., Sautiére P., Dachary J., Mazat J., Michalski J., Velours J., Mena-López R., and Delacourte A. Association of ATP synthase alpha-chain with neurofibrillary degeneration in Alzheimer's disease. Neuroscience 117 (2003) 293-303
29. Jana N., Tanaka M., Wang G., and Nukina N. Polyglutamine length-dependent interaction of Hsp40 and Hsp70 family chaperones with truncated N-terminal huntingtin: their role in suppression of aggregation and cellular toxicity. Hum. Mol. Genet. 9 (2000) 2009-2018
30. Wyttenbach A., Sauvageot O., Carmichael J., Diaz-Latoud C., Arrigo A., and Rubinsztein D. Heat shock protein 27 prevents cellular polyglutamine toxicity and suppresses the increase of reactive oxygen species caused by huntingtin. Hum. Mol. Genet. 11 (2002) 1137-1151
31. Kobayashi Y., Kume A., Li M., Doyu M., Hata M., Ohtsuka K., and Sobue G. Chaperones Hsp70 and Hsp40 suppress aggregate formation and apoptosis in cultured neuronal cells expressing truncated androgen receptor protein with expanded polyglutamine tract. J. Biol. Chem. 275 (2000) 8772-8778
32. Rujano M., Kampinga H., and Salomons F. Modulation of polyglutamine inclusion formation by the Hsp70 chaperone machine. Exp. Cell Res. 313 (2007) 3568-3578
33. Cummings C., Sun Y., Opal P., Antalffy B., Mestril R., Orr H., Dillmann W., and Zoghbi H. Over-expression of inducible HSP70 chaperone suppresses neuropathology and improves motor function in SCA1 mice. Hum. Mol. Genet. 10 (2001) 1511-1518
34. Warrick J., Chan H., Gray-Board G., Chai Y., Paulson H., and Bonini N. Suppression of polyglutamine-mediated neurodegeneration in Drosophila by the molecular chaperone HSP70. Nat. Genet. 23 (1999) 425-428
35. Chai Y., Koppenhafer S., Bonini N., and Paulson H. Analysis of the role of heat shock protein (Hsp) molecular chaperones in polyglutamine disease. J. Neurosci. 19 (1999) 10338-10347
36. Chan H., Warrick J., Gray-Board G., Paulson H., and Bonini N. Mechanisms of chaperone suppression of polyglutamine disease: selectivity, synergy and modulation of protein solubility in Drosophila. Hum. Mol. Genet. 9 (2000) 2811-2820
37. Adachi H., Katsuno M., Minamiyama M., Sang C., Pagoulatos G., Angelidis C., Kusakabe M., Yoshiki A., Kobayashi Y., Doyu M., and Sobue G. Heat shock protein 70 chaperone overexpression ameliorates phenotypes of the spinal and bulbar muscular atrophy transgenic mouse model by reducing nuclear-localized mutant androgen receptor protein. J. Neurosci. 23 (2003) 2203-2211
38. Bauer P., Wong H., Oyama F., Goswami A., Okuno M., Kino Y., Miyazaki H., and Nukina N. Inhibition of Rho kinases enhances the degradation of mutant huntingtin. J. Biol. Chem. 284 (2009) 13153-13164
39. Miller V., Nelson R., Gouvion C., Williams A., Rodriguez-Lebron E., Harper S., Davidson B., Rebagliati M., and Paulson H. CHIP suppresses polyglutamine aggregation and toxicity in vitro and in vivo. J. Neurosci. 25 (2005) 9152-9161
40. Goswami A., Dikshit P., Mishra A., Mulherkar S., Nukina N., and Jana N. Oxidative stress promotes mutant huntingtin aggregation and mutant huntingtin-dependent cell death by mimicking proteasomal malfunction. Biochem. Biophys. Res. Commun. 342 (2006) 184-190
41. Jana N., Dikshit P., Goswami A., Kotliarova S., Murata S., Tanaka K., and Nukina N. Co-chaperone CHIP associates with expanded polyglutamine protein and promotes their degradation by proteasomes. J. Biol. Chem. 280 (2005) 11635-11640
42. Al-Ramahi I., Lam Y., Chen H., de Gouyon B., Zhang M., Pérez A., Branco J., de Haro M., Patterson C., Zoghbi H., and Botas J. CHIP protects from the neurotoxicity of expanded and wild-type ataxin-1 and promotes their ubiquitination and degradation. J. Biol. Chem. 281 (2006) 26714-26724